The drug was shown to be as safe as placebo on a composite of CV death, nonfatal myocardial infarction or nonfatal stroke
News
Government authorises use of dexamethasone for COVID-19
Doctors can now administer the an anti-inflammatory to all UK hospitalised COVID-19 patients requiring oxygen
Researchers develop highly sensitive blood test for cancer
Researchers have developed a new way of analysing cancer patients’ blood for evidence of the disease that could be up to ten times more sensitive than previous methods.
UK launches world’s first ‘subscription-style’ payment model for antibiotics
The scheme could give NHS patients access to new antibiotics as early as 2022
Novartis’ Ilaris first drug approved for Still’s disease
Ilaris works by blocking the effects of IL-1 and suppressing inflammation in patients with this autoinflammatory disorder
Evgen’s SFX-01 selected for COVID-19 trial
The company is participating in LifeArc’s funding initiative for COVID-19 clinical trials
Final NICE green light for Janssen’s Stelara in UC
The drug will be funded on the NHS to treat ulcerative colitis under certain conditions
GSK and IDEAYA partner in synthetic lethality
The deal gives GSK access to IDEAYA’s MAT2A, Pol Theta, and Werner Helicase programmes
MHRA suspends COVID-19 hydroxychloroquine trials
The move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised with COVID-19
Dexamethasone cut deaths by 35% in ventilated COVID-19 patients
The steroid drug significantly reduced deaths in hospitalised patients with severe respiratory complications
Jazz’ small cell lung cancer therapy wins US green light
The approval gives patients who relapse a new second-line option for the first time in nearly 20 years
Celltrion’s infliximab biosimilar to be tested for COVID-19
Infliximab has been chosen because of its effective role in treating autoimmune and inflammatory conditions and established safety profile
NHS signs ‘landmark’ deal with Microsoft
Under the deal, Microsoft 365 will be deployed to as many as 1.2 million staff across NHS organisations
AbbVie’s Venclyxto shows promise as AML treatment
The drug is already on the market to treat chronic lymphocytic leukaemia (CLL)
MPs launch inquiry into UK asthma outcomes
Improvements in key asthma outcomes have stalled in the last decade
